Transforming preventative care in the NHS – Pharmaceutical Technology

The latest webinar from EMIS, a leading healthcare technology provider, showcased its Pathway platform—a robust tool designed to improve the delivery of preventative care interventions and address critical pressures facing the NHS.

Featuring insights from EMIS’s Jamie Cole, director of partners and life sciences, Ian Wood, NHS GP and a clinical director, and Jenny Hamilton, product manager, the session illuminated the innovative ways in which EMIS leverages its vast technological and data expertise to support healthcare service transformation.

Tackling NHS challenges with preventative care

In this webinar, Dr Ian Wood outlines the current pressures on the NHS, highlighting the growing demand for care due to an ageing population and the increasing prevalence of chronic conditions. With more than two million patients waiting between six and twelve months for care and the NHS workforce under strain, traditional reactive healthcare approaches are struggling to cope.

Against this backdrop, preventative care stands out as a cost-effective solution. Dr Wood emphasised that addressing health issues earlier not only improves outcomes but also reduces strain on primary care services. However, achieving this shift requires a technological infrastructure capable of identifying at-risk patients and efficiently coordinating interventions.

With more than 10,000 healthcare organisations relying on its software, EMIS is uniquely positioned to harness the power of its technology to drive meaningful change. At the heart of this transformation is Pathway, a tool built on EMIS’s cloud-based platform. It leverages the extensive repository of primary care data to identify patient cohorts that would benefit from early intervention.

The Pathway platform has already proven its value, facilitating targeted hepatitis C programmes in collaboration with NHS and industry partners. By identifying patients most at risk and connecting them with specialist teams, the initiative has streamlined care pathways, demonstrating how precision-driven technology can enhance efficiency and outcomes.

Working in partnership with life science organisations

Life science organisations are pivotal in developing cutting-edge treatments that transform and save millions of lives. Many patients who could benefit from these innovations and other healthcare interventions are identifiable within primary care data. By collaborating with life science organisations and the NHS, Pathway leverages advanced case finding technology to unlock the potential of healthcare data. This approach enables the identification of at-risk patients, facilitating proactive and preventative treatments and interventions that improve patient outcomes.

Pathway’s modular design can be used to target a wide range of disease areas, from chronic kidney disease to cardiovascular conditions, adapting to meet regional and national specific healthcare needs. Future advancements, including the integration of AI and machine learning, promise to expand its capabilities further, enabling even more precise patient identification and intervention.

A glimpse into the future

The Pathway platform’s impact is already evident, with numerous projects underway for 2025. These initiatives span from identifying patients at risk of psychosis to enabling care optimisation of cardiovascular disease. Such projects are not only enhancing patient outcomes but are also laying the groundwork for a more efficient and equitable healthcare system.

EMIS’s commitment to innovation, coupled with its focus on collaboration, positions it as a pivotal player in the evolution of preventative care. For healthcare providers, life sciences companies, and policymakers alike, Pathway offers a compelling blueprint for addressing the NHS’s most urgent challenges.

For a deeper dive into the insights shared during the webinar and to explore the transformative potential of EMIS Pathway, download the full session now.

© EMIS Group Limited. All Rights Reserved